Triple-negative breast cancer (TNBC) is defined as a tumor lacking estrogen (ER) and progesterone (PR) receptor expression and human epidermal growth factor receptor 2 (HER-2) overexpression/amplification. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.